Boston Scientific Corp
(FRA:BSX)
€
38.95
+0.17 (+0.43%)
Market Cap: 58.43 Bil
Enterprise Value: 67.05 Bil
PE Ratio: 18.73
PB Ratio: 2.57
GF Score: 74/100 Boston Scientific Corp at Evercore HealthCONx Conference Transcript
Dec 04, 2019 / 04:00PM GMT
Release Date Price:
€38.48
(+0.79%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD
Okay. I think we'll get started here. Thanks everyone for joining us this morning. Vijay Kumar, I cover devices and tools at Evercore. Happy to have with us, Boston Scientific, in their backyard. We have representing the company, Susie Lisa; and Lauren Tengler from the IR team. Susie, Lauren, welcome and thank you for participating.
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR
Thank you.
Lauren Tengler
Boston Scientific Corporation - Director of IR
Thank you.
Questions & Answers
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD
So I guess just maybe starting with what happened in 3Q. I mean organic came in really, really strong. I thought, even ex the extra selling days, organic came in really, really strong. Maybe -- was there anything that surprised you guys? I know you guys said all this -- the guidance that's baked in this
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot